About Okomera
Okomera is a company based in Paris (France) founded in 2020 by Aimee Wessel, Sandra Jernstrom, Raphael Tomasi, and Charles Baroud.. Okomera has raised $11.17 million across 1 funding round from investors including Polytechnique Ventures, Berkeley SkyDeck Fund and Resonance. Okomera offers products and services including 3D Organoid Screening Platform and AI Analysis Platform. Okomera operates in a competitive market with competitors including Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others.
- Headquarter Paris, France
- Founders Aimee Wessel, Sandra Jernstrom, Raphael Tomasi, Charles Baroud
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.17 M (USD)
in 1 rounds
-
Latest Funding Round
$11.17 M (USD), Seed
Dec 20, 2023
-
Investors
Polytechnique Ventures
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Okomera
Okomera offers a comprehensive portfolio of products and services, including 3D Organoid Screening Platform and AI Analysis Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates high-throughput screening of organoids for cancer research
Provides end-to-end AI for organoid data processing in drug testing
Funding Insights of Okomera
Okomera has successfully raised a total of $11.17M through 1 strategic funding round. The most recent funding activity was a Seed round of $11.17 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $11.2M
-
First Round
First Round
(20 Dec 2023)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Seed - Okomera | Valuation | Polytechnique Ventures , Berkeley SkyDeck Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Okomera
Okomera has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Polytechnique Ventures, Berkeley SkyDeck Fund and Resonance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A seed fund is managed to support startups from Ecole Polytechnique ecosystem.
|
Founded Year | Domain | Location | |
|
Investments are directed toward early-stage tech startups by Resonance.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Okomera
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Okomera
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Okomera Comparisons
Competitors of Okomera
Okomera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Okomera
Frequently Asked Questions about Okomera
When was Okomera founded?
Okomera was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Where is Okomera located?
Okomera is headquartered in Paris, France.
Who is the current CEO of Okomera?
Aimee Wessel is the current CEO of Okomera. They have also founded this company.
Is Okomera a funded company?
Okomera is a funded company, having raised a total of $11.17M across 1 funding round to date. The company's 1st funding round was a Seed of $11.17M, raised on Dec 20, 2023.
What does Okomera do?
Okomera was founded in 2020 in Paris, France, within the biotechnology sector. A device employing microfluidic chips for in vitro cancer testing is developed. Proprietary technology is utilized for personalized treatments and evaluation of cancer cells in 3D spheroids. Tumor biopsies are analyzed through this method, supporting research in oncology applications.
Who are the top competitors of Okomera?
Okomera's top competitors include Guardant Health, Juno Therapeutics and Foundation Medicine.
What products or services does Okomera offer?
Okomera offers 3D Organoid Screening Platform and AI Analysis Platform.
Who are Okomera's investors?
Okomera has 4 investors. Key investors include Polytechnique Ventures, Berkeley SkyDeck Fund, Resonance, and Otium Capital.